Ophir Vermesh, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, OX40 | 2 | 2020 | 44 | 0.340 |
Why?
|
Contrast Media | 3 | 2018 | 5302 | 0.300 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1229 | 0.230 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10181 | 0.200 |
Why?
|
Blood Proteins | 4 | 2017 | 1163 | 0.200 |
Why?
|
Copper Radioisotopes | 2 | 2020 | 89 | 0.190 |
Why?
|
Interferon-beta | 1 | 2020 | 345 | 0.150 |
Why?
|
Molecular Imaging | 3 | 2022 | 817 | 0.150 |
Why?
|
Ultracentrifugation | 1 | 2017 | 183 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2018 | 13238 | 0.130 |
Why?
|
Nanospheres | 1 | 2015 | 21 | 0.130 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2011 | 809 | 0.120 |
Why?
|
Hodgkin Disease | 1 | 2022 | 1381 | 0.120 |
Why?
|
Glass | 1 | 2015 | 115 | 0.120 |
Why?
|
Biosensing Techniques | 1 | 2020 | 679 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 182 | 0.110 |
Why?
|
Ferric Compounds | 1 | 2015 | 378 | 0.110 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 937 | 0.110 |
Why?
|
Lymphoma | 1 | 2022 | 1898 | 0.110 |
Why?
|
Oxides | 1 | 2015 | 401 | 0.110 |
Why?
|
Exosomes | 1 | 2017 | 423 | 0.110 |
Why?
|
Nanotechnology | 2 | 2016 | 708 | 0.110 |
Why?
|
Transfection | 1 | 2020 | 5783 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2018 | 940 | 0.100 |
Why?
|
Folic Acid | 1 | 2018 | 1303 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5497 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1442 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2630 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1008 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1044 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1400 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2011 | 218 | 0.080 |
Why?
|
Microchip Analytical Procedures | 1 | 2008 | 29 | 0.080 |
Why?
|
Positron-Emission Tomography | 3 | 2022 | 6436 | 0.080 |
Why?
|
Microfluidics | 2 | 2016 | 655 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3022 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 437 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2017 | 3204 | 0.070 |
Why?
|
Plasma | 1 | 2008 | 583 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4622 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3526 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1630 | 0.060 |
Why?
|
Nanoparticles | 1 | 2015 | 1935 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2011 | 1866 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5317 | 0.040 |
Why?
|
Microbubbles | 1 | 2020 | 128 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16871 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5247 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 630 | 0.040 |
Why?
|
Point-of-Care Systems | 2 | 2020 | 1208 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2020 | 1335 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2262 | 0.030 |
Why?
|
Lasers | 1 | 2020 | 953 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2018 | 777 | 0.030 |
Why?
|
Phosphorus Compounds | 1 | 2015 | 4 | 0.030 |
Why?
|
Sodium Compounds | 1 | 2015 | 35 | 0.030 |
Why?
|
Calcium Compounds | 1 | 2015 | 38 | 0.030 |
Why?
|
Humans | 15 | 2022 | 759255 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2007 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1836 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2628 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 1837 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36160 | 0.030 |
Why?
|
Animals | 6 | 2020 | 167838 | 0.020 |
Why?
|
Mice | 4 | 2020 | 81138 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 914 | 0.020 |
Why?
|
Proteins | 2 | 2020 | 6029 | 0.020 |
Why?
|
Cell Membrane | 1 | 2020 | 3683 | 0.020 |
Why?
|
Neoplasms | 2 | 2017 | 22019 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4573 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 2011 | 360 | 0.020 |
Why?
|
Nylons | 1 | 2009 | 46 | 0.020 |
Why?
|
Peroxides | 1 | 2009 | 73 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4262 | 0.020 |
Why?
|
Dimethylpolysiloxanes | 1 | 2009 | 143 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2010 | 687 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2532 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2222 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9528 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5209 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11123 | 0.020 |
Why?
|
Immunoassay | 1 | 2010 | 748 | 0.020 |
Why?
|
Pressure | 1 | 2009 | 1155 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2347 | 0.020 |
Why?
|
Hydrogels | 1 | 2011 | 725 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4040 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4883 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2011 | 1340 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5796 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14652 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2218 | 0.010 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2008 | 432 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9194 | 0.010 |
Why?
|
Astrocytes | 1 | 2011 | 1333 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1914 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3774 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5955 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3797 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18110 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9374 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8491 | 0.010 |
Why?
|
Proteome | 1 | 2008 | 1849 | 0.010 |
Why?
|
DNA | 1 | 2010 | 7237 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18968 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20461 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8929 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20031 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29877 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80121 | 0.010 |
Why?
|
Aged | 1 | 2016 | 168617 | 0.000 |
Why?
|
Middle Aged | 1 | 2016 | 219653 | 0.000 |
Why?
|
Adult | 1 | 2016 | 219390 | 0.000 |
Why?
|
Male | 1 | 2016 | 358719 | 0.000 |
Why?
|
Female | 1 | 2016 | 390240 | 0.000 |
Why?
|